William H Hilderbrand

Title: Innovations by William H. Hilderbrand: Pioneering Breast Cancer Detection

Introduction

William H. Hilderbrand, an innovative inventor based in Edmond, OK, has made significant contributions to the field of breast cancer research. With a total of two patents to his name, he has developed groundbreaking technologies aimed at identifying tumor-specific antigens, which play a crucial role in diagnosis and therapy for breast cancer.

Latest Patents

Hilderbrand's latest patents focus on the identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies. This invention describes novel tumor-specific phosphorylated peptides, along with the nucleic acids encoding those peptides and antibodies generated against them. The genes, peptides, and antibodies detailed in his patents have potential applications as diagnostic indicators for the presence of breast cancer and may also be utilized therapeutically for treatment.

Career Highlights

Throughout his career, Hilderbrand has collaborated with prominent organizations, including Agenus Inc. and the University of Oklahoma. His work has been instrumental in advancing the understanding and treatment of breast cancer through innovative methodologies and technologies.

Collaborations

Hilderbrand has worked alongside notable colleagues such as Donald F. Hunt and Andrew Norris. These collaborations have further enriched his research endeavors and contributed to the development of effective cancer diagnostics and treatment options.

Conclusion

William H. Hilderbrand's contributions to breast cancer research through his innovative patents and collaborative efforts exemplify the importance of invention in the medical field. His work not only aids in the early detection of cancer but also paves the way for therapeutic advancements that can significantly improve patient outcomes.